These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2005-000690-22 A phase II Clinical Study of CP-4055 in patients with metastatic melanoma not previous treated with chemotherapy bad-data
Exempt 2006-000868-83 A Phase I/II Study of CP-4055 in Patients with Refractory/Relapsed Hematologic Malignancies 2009-07-02 not-yet-due
Not reported 2006-006766-41 A phase II Clinical Study of CP-4055 as second line therapy in patients with advanced colorectal cancer 2008-09-01 due-trials
Not reported 2007-000915-28 A multicentre, dose finding, phase II Study of CP-4055 in combination with Sorafenib in patients with metastatic malignant melanoma 2008-08-25 due-trials
Completed, but no date 2007-003323-20 A Phase I/II Study of CP-4055 in Patients with Platinum Resistant Ovarian Cancer bad-data
Ongoing 2007-007476-42 A phase II study of CP-4126 in patients with advanced pancreatic cancer not-yet-due
Listed as ongoing, but also has a completion date 2008-008518-38 A Phase II Study of CP-4055 plus Idarubicin as Second Course Remission-Induction Therapy in Patients with Acute Myeloid Leukaemia 2013-05-07 bad-data
Listed as ongoing, but also has a completion date 2009-014445-80 A Randomised Phase III Study of Elacytarabine vs. Investigator’s Choice in Patients with Late Stage Acute Myeloid Leukaemia 2013-05-17 bad-data